Latest news
30-03-2022 - Annual Deadline Announced for ADDF/AFTD Accelerating Drug Discovery for Frontotemporal Degeneration
Funding is available to accelerate and support innovative small molecule and biologic drug discovery programmes for frontotemporal degeneration.
Founded in 1998 and based in the US, the Alzheimer's Drug Discovery Foundation (ADDF) seeks to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.
[...]